Wikipedia -WSS

Wikipedia

author：fashion 2025-10-01 00:05:45 - browse：3

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： A strong 6.5

WSS

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

Pfizer's RSV vaccine recommended for approval in Europe

Asa Hutchinson previews new plan to reform federal law enforcement if elected in 2024

A Theranos scientist

Biden White House, tech companies launch new safeguards around emerging AI technology

focus

Wikipedia

focus

How to save PrEP access — and even expand it

Phoenix breaks record with 19 consecutive days above 110 degrees Fahrenheit

Malaria cases in Florida and Texas: Here’s what you need to know

Biden White House, tech companies launch new safeguards around emerging AI technology

Apple is now the first public company to be valued at $3 trillion

Listen: BridgeBio's big week & Lilly's Alzheimer's data

In age of alternative facts, a scholarly course on calling out crap

A look at other Americans who have crossed into North Korea over the years

23andMe had bad news about my health. I wish a person had delivered it

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

focus

Lack of darker skin in textbooks, journals harms patients of color

Lack of darker skin in textbooks, journals harms patients of color

What is the Turing Test that determines if computers can think?

A Theranos scientist

Study: Hearing aids may slow cognitive decline in those at risk

Study: Hearing aids may slow cognitive decline in those at risk

leisure time

leisure time

Wikipedia

focus